Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Clare Rebbeck, Charles Vanderburg, Sara Larriba, Muthuswamy Balasubramanyam, Johannes Grillari, Serena Lucotti, Viviana Bumaschny, Richard Keijzer, Carolyn Klinge, Hanjoong Jo

Premium

Exiqon announced 10 winners of its 2012 grant program, which provides microRNA researchers with awards that can be used to purchase Exiqon miRNA products and services.

This year's winner's include Cold Spring Harbor Laboratory's Clare Rebbeck; Harvard Medical School's Charles Vanderburg; Bellvitge Biomedical Research Institute's Sara Larriba; and Madras Diabetes Research Foundation's Muthuswamy Balasubramanyam.

Also winning grants are Johannes Grillari of Vienna's University of Natural Resources and Life Sciences; the Institute of Clinical Physiology's Serena Lucotti; the University of Buenos Aires' Viviana Bumaschny; Richard Keijzer of the University of Manitoba: Carolyn Klinge of the University of Louisville School of Medicine; and Hanjoong Jo of Emory University.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.